Biosimilars Forum Calls For Further Action On Biden’s Competition Order

Impending Humira Launches Would Benefit From Increased Competition

Generics Bulletin sits down with Biosimilars Forum executive director Julie Reed to discuss preparing the HHS for Humira biosimilars, what more the agency could do for the industry and the Forum’s priorities over the next year.

Row of microphones
Tackling misinformation about interchangeability is a key priority of the Biosimilars Forum. • Source: Shutterstock

More from Biosimilars

More from Products